StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)

Close on Nov 17, 2026Market cap $3.49BP/E –Yield –

Parabilis Medicines total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Parabilis Medicines's total debt was $6.41M at Jun 30, 2026. For fiscal 2025 it was $13.68M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.68M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.41M–
Q4 FY2025Dec 31, 2025$13.68M–

More Parabilis Medicines figures

See a number that looks wrong?